Aims
Introduction
Nitric oxide (NO) plays an integral role in sustaining vascular homeostasis on a number of levels including maintaining vascular tone, inhibiting thrombosis, and regulating the expression of endothelial adhesion molecules. For years, NO was considered to be strictly a paracrine signalling molecule whose short half-life, limited diffusibility, and rapid reaction rate with haem proteins made it an optimal signalling molecule for such pathways as the activation of soluble guanylate cyclase leading to cyclic guanosine monophosphate (cGMP)-dependent vasodilation. However, accumulating evidence demonstrates that the molecule nitrite (NO 2 
2
) represents a circulating reservoir of endocrine NO that is responsible for mediating responses, such as hypoxic vasodilation. 1 -3 Nitrite, the one electron oxidation product of NO, is a dietary component and is present basally in red blood cells (RBC; 290 nM) and plasma (120 nM). 4 In tissues, nitrite is reduced along a physiological oxygen and pH gradient by a number of enzymes to mediate responses such as the modulation of protein expression, 5 angiogenesis, 6 regulation of metabolism, [7] [8] [9] and cytoprotection after ischaemia/reperfusion injury. 10 -17 In the blood, haemoglobin (Hb) is the predominant nitrite reductase and its reaction with nitrite has been proposed as a mechanism of hypoxic vasodilation. 18 -22 In this reaction, deoxygenated ferrous haemoglobin (deoxyHb) reduces nitrite in the presence of a proton, yielding NO and methaemoglobin (metHb) (Reaction 1) 23, 24 :
The NO generated binds unreacted deoxyHb to form iron-nitrosyl Hb (Reaction 2):
Biochemical analysis of this reaction has demonstrated that Hb-catalysed nitrite reduction is regulated by oxygen and pH, as well as by the allosteric structural transition of the tetrameric Hb molecule. 19, 20, 22 This allosteric regulation is driven by the balance of vacantbinding sites for nitrite on the Hb tetramer, which are maximal in the deoxygenated (T) state, vs. the ability of the haem to donate an electron to nitrite, which is optimal in the oxygenated (R) state. 20 This results in maximal Hb-catalysed nitrite reduction occurring at the oxygen tension at which the Hb molecule is half-saturated with oxygen (P 50 ). 20 These biochemical observations are supported by in vitro aortic ring experiments in which physiological concentrations of nitrite vasodilate rings only in the presence of deoxyHb, and this vasodilation is initiated at the Hb P 50 . 19 Despite accumulating evidence for the role of nitrite reduction in mediating hypoxic vasodilation, scepticism remains as to whether this reaction can generate NO that is able to leave the Hb molecule to signal at distant targets. Thus, a physiologically relevant, vessel-independent method is needed to measure NO generated from this reaction. Mitochondrial cytochrome c oxidase (complex IV) is responsible for 99% of oxygen consumption in the body and is the predominant target for NO within mitochondria. The active site of this enzyme, the binuclear centre, consists of haemea 3 and copper B , to which oxygen binds and is reduced to water to act as the terminal electron acceptor in the respiratory chain. The binuclear centre is also a major position of respiratory regulation due to the ability of NO to bind a reduced catalytic intermediate of this site, precluding the binding of oxygen, and thus resulting in the inhibition of mitochondrial respiration. 25, 26 Importantly, this NO-dependent inhibition of respiration is more potent as oxygen concentration is decreased, such that nanomolar concentrations of NO elicit significant inhibition in hypoxia. 27, 28 Furthermore, this inhibition is completely reversible. 26, 28 Physiologically, this phenomenon is involved in a number of processes including the extension of tissue oxygen gradients, 29, 30 regulation of HIF-1a, 31 and the modulation of mitochondrial reactive oxygen species (ROS) generation 32 for signalling. However, the ability to measure respiratory inhibition in isolated mitochondria in vitro and the sensitivity of respiration to low levels of NO in hypoxia make it ideal for its use as an indicator of NO generation. Herein, using NO-dependent mitochondrial inhibition as a unique NO biosensor, we demonstrate that RBC and Hb-catalysed nitrite reduction result in physiologically relevant levels of bioavailable NO. We describe two methods of measuring hypoxic mitochondrial respiratory inhibition, a deoxygenating kinetic system and an open-flow assay, and use these systems to demonstrate the modulation of this nitrite reductase activity by oxygen and allosteric modulators of Hb.
Methods

Materials
All reagents were purchased from Sigma (St Louis, MO, USA).
Mitochondrial isolation and respiration
Liver mitochondria were isolated as described previously 9 
Cardiac cGMP
Isolated rat hearts were perfused with nitrite or RBCs in hypoxic buffer (Krebs -Hanseleit bubbled with 5%CO 2 /94% N 2 /1% O 2 gas). Hearts were perfused for 5 min and then flash-frozen and homogenized. cGMP levels were measured by competition ELISA using a kit (Cayman Chemicals, Ann Arbor, MI, USA).
RBCs and Hb
Healthy human RBCs were acquired after informed consent in accordance with protocols approved by the Institutional Review Board of the NIH and the University of Pittsburgh and in compliance with the Helsinki Agreement. RBCs were washed with PBS at pH 7.4 and used immediately.
Hb was prepared by hypotonically lysing RBCs, discarding the membrane fraction, and then dialysing. Hb was treated with modulators as described previously 20 and as outlined in Supplementary material online, Methods.
Statistics
All data are means + SEM. Statistical differences between groups were determined by non-parametric Mann-Whitney analysis. Statistical significance was determined as P , 0.05.
Results
Nitrite inhibits mitochondrial respiration in the presence of deoxygenated RBCs
In experiments to determine whether nitrite could be reduced to NO by deoxygenated RBCs and subsequently inhibit respiration, mitochondria were incubated with RBCs and stimulated to respire. Mitochondria, alone or in the presence of nitrite (0-40 mM), consumed oxygen at a constant rate until the respiratory chamber became anoxic. In the presence of RBCs (0.3% haematocrit 2 0.3% of the reaction mixture volume, resulting in 50 mM haem) alone, the rate of oxygen consumption appeared to decrease as the oxygen tension fell below 20% (40 mmHg) ( Figure 1A ). This nitritemediated inhibition of respiration was completely reversed by the NO scavenger C-PTIO (100 mM), confirming that the species generated was NO and that inhibition occurred through the reversible binding to cytochrome c oxidase ( Figure 1A and B).
To validate this experimental model, another bioassay for NO production was used. Isolated rat hearts were perfused with hypoxic (1% Detection of nitrite-dependent NO generation by mitochondrial inhibition O 2 ) buffer containing nitrite, RBCs, or nitrite and RBCs together. Cardiac cGMP levels were measured as a marker of NO and showed a significant increase only after perfusion with nitrite and RBCs together, confirming that deoxygenated RBCs catalyse the reduction of nitrite to NO ( Figure 1C) .
Characterization of the mitochondrial experimental system demonstrated that RBC-dependent, nitrite-mediated inhibition of respiration was dependent on the time of nitrite addition in relation to the rate of RBC and mitochondrial deoxygenation. The addition of nitrite (20 mM) to the chamber containing mitochondria and RBCs (0.3% haematocrit) at various stages of deoxygenation resulted in variable extents of inhibition. The introduction of nitrite in the system at 70% oxygen demonstrated a significant inhibition, whereas incubation of nitrite with RBCs from the beginning of the experiment failed to inhibit respiration ( Figure 2A ). The magnitude of effect was greatest when nitrite was introduced at 60-70% oxygen tension, and no significant effect on respiration was observed with nitrite addition above 75% or below 50% oxygen ( Figure 2B ). The lack of effect with early nitrite addition is likely due to the consumption of nitrite by its reaction with oxyhaemoglobin. This was confirmed by absorption spectra of the RBCs from the reaction mixture taken at the end of the experiment, which showed that the RBCs were completely oxidized (data not shown).
The importance of the rate of deoxygenation was corroborated by comparing nitrite-RBC-dependent inhibition of respiration in mitochondrial preparations with differing initial respiratory rates (measured before the addition of RBCs or treatment with nitrite). The magnitude of RBC-nitrite-mediated inhibition, quantified as the difference in rate between the mitochondria incubated with RBCs alone and RBCs in the presence of nitrite, was biphasic ( Figure 2C) .
Next, the effect of haematocrit and nitrite concentration on the inhibition of respiration was tested. The effect of haematocrit was biphasic, showing an increase in effect at low haematocrits, and a peak at 0.35% haematocrit, after which the effect decreased ( Figure 3A) . This is consistent with an NO-scavenging effect at high haematocrits. The extent of inhibition in the presence of RBCs (0.35% haematocrit) was dependent on the concentration of nitrite between 2.5 and 30 mM nitrite ( Figure 3B ).
The open-flow model of hypoxic inhibition
We next determined whether mitochondria could be used as a sensor for NO generated by nitrite reduction catalysed by free Hb. The assay described above was ineffective for measuring Hb-catalysed nitrite reduction because the much higher oxygen affinity of cell-free Hb (P 50 10 mmHg) rendered it impossible to collect data between the time of Hb deoxygenation and anoxia. To circumvent this problem, a new assay system was developed in which respiring mitochondria were allowed to make the chamber anoxic. At the point of anoxia, the chamber was opened and equilibrated with room air. Although oxygen diffusion from the air into the chamber was constant, no change was observed in the electrode trace due to the rapid respiratory rate of the mitochondria. In this 'open flow' model, mitochondria maintained anoxia in the chamber until substrate was exhausted. Once respiratory substrate was exhausted, the chamber accumulated oxygen. When an irreversible respiratory inhibitor, cyanide, was added to completely inhibit respiration, oxygen diffusing into the chamber was not consumed and accumulated within the chamber immediately after the addition, causing the oxygen trace to deviate from zero ( Figure 4A ). The addition of an NO donor (DetaNONOate) showed a lag time before the accumulation of oxygen in the chamber. The time between the addition of the NO donor and the deviation of the trace from anoxia ('time to inhibition') was representative of partial inhibition of respiration and inversely correlated with the concentration of NO donor ( Figure 4A and B). To rule out the possibility that NO release by the donor was delayed in this system, NO release from the donor was measured polarographically in the absence of mitochondria. As expected, NO gradually accumulated in the chamber after the donor was added, consistent with the immediate decay of the donor (Supplementary material online, Figure S1 ). When the extent of inhibition was calculated based on the time to inhibition compared with cyanide-mediated inhibition (100% inhibition) and exhaustion of substrate (0% inhibition), NO showed a concentration-dependent inhibition curve ( Figure 4C) . It is important to note that although micromolar concentrations of the NO donor were used, the actual concentration of NO in the chamber was much lower due to the half-life of the donor (20 h at 378C). Calculation of NO concentration from the half-life of the donor suggests that inhibition was detected by the oxygen electrode when 75-100 nM of NO accumulated in the chamber, consistent with the range of NO previously reported to inhibit respiration in isolated mitochondria. 27, 28, 33 To further validate this assay system, isolated mitochondria were first incubated with RBCs. In this assay, nitrite (20 mM) or RBCs (0.35% haematocrit) alone had no significant effect on the time to mitochondrial inhibition. However, oxygen accumulation in the chamber occurred significantly earlier when mitochondria were incubated with RBCs and nitrite was added to the deoxygenated chamber, indicative of respiratory inhibition ( Figure 5A ). Similar results were observed when heart mitochondria respiring on pyruvate were used instead of liver mitochondria, demonstrating that the effect is not specific to liver mitochondria or a particular respiratory substrate (Supplementary material online, Figure S2 ). Interestingly, in the openflow system, like the deoxygenation assay, nitrite was only effective in inhibiting respiration when added to the deoxygenated chamber, as the incubation of RBCs with nitrite from the beginning of the assay had no effect on respiration. Nitrite -RBC-mediated inhibition of respiration was not significantly changed by the presence of superoxide dismutase (100 mM) or treatment with the nitric oxide synthase (NOS) inhibitor L-NAME (200 mM), ruling out a role for ROS or NOS in this effect. Addition of C-PTIO to the incubation prevented the inhibition of respiration ( Figure 5A) .
To determine whether deoxygenated free Hb could reduce nitrite to NO and subsequently inhibit mitochondrial respiration, purified Hb (10-200 mM) was incubated with mitochondria. The mitochondria showed no respiratory inhibition in the presence of nitrite or Hb alone. However, when nitrite was added to the incubation containing mitochondria and Hb, significant inhibition of respiration (79 + 8%) was observed. Addition of nitrite to mitochondria incubated with varying concentrations of Hb demonstrated a biphasic response, with the greatest effect at 25 mM Hb ( Figure 5B and C ).
Allosteric modulators regulate Hb -nitrite-mediated respiratory inhibition
The rate of Hb's nitrite reductase activity is regulated by its allosteric structural transition between the deoxygenated (T) and oxygenated (R) state. This regulation is due to the balance between the necessity for nitrite-binding sites on the Hb tetramer, which are maximal in T state, vs. the ability of the haem to donate an electron to nitrite (a negative redox potential), which is maximal in the R-state Detection of nitrite-dependent NO generation by mitochondrial inhibition tetramer. 20, 22 Hence, the reduction of nitrite with 100% deoxyHb (T state) is relatively slow (bimolecular rate constant: 0.17 vs. 6 M 21 s 21 in R state), but as the reaction proceeds, products of the reaction (met and iron -nitrosyl haem) stabilize the R-state tetramer and accelerate the rate of reaction. 20, 34 To determine whether allosteric modulation of the Hb molecule could alter the rate of deoxyHb-catalysed nitrite reduction and change the extent of mitochondrial inhibition, mitochondria were incubated with deoxyHb treated with N-ethylmaleimide (NEM), which decreases the haem redox potential (E 1/2 ¼ 85 vs. 45 m/V for untreated Hb) and accelerates the Hb -nitrite reaction. 19, 20 Addition of nitrite to this incubation increased the extent of inhibition (80 + 7%) in comparison with untreated Hb (57 + 6%), consistent with an increased rate of nitrite reduction ( Figure 6A and B) . In contrast, inositol hexophosphate (IHP) increases the redox potential of Hb (E 1/2 ¼ 135 m/V) and thus decreases the rate of Hb-catalysed nitrite reduction. 19, 20 Consistent with this, nitrite elicited a decreased extent of inhibition (22 + 11%) when mitochondria were incubated in the presence of IHP-treated Hb ( Figure 6A and B) .
The cysteine-93 residue on the beta chain of the Hb tetramer regulates haem redox potential. To test whether the b93cys is involved in hypoxic NO generation from nitrite, mitochondria were incubated with recombinant mouse Hb in which the b93cys was replaced with alanine. 19, 35 Addition of nitrite to the incubation containing the b93 alanine mutant Hb resulted in a greater extent of respiratory inhibition (66 + 6%) than in the presence of wildtype Hb (54 + 4%) ( Figure 6C ). These studies indicate that cysteine modification or mutation increases the NO production from nitrite, and indicates that an S-nitrosothiol is not a required intermediate in NO formation from nitrite.
To determine whether stabilization of R-state Hb could increase the rate of nitrite reduction and increase the extent of mitochondrial inhibition, fully oxygenated Hb was treated with low concentrations of the NO donor ProliNONOate to make partial methaem R-state tetramers (ferric Hb has R-state character). Addition of nitrite to mitochondria incubated with partially oxidized Hb showed a biphasic response in the extent of inhibition of respiration, with low concentrations of methaem (4-42%) increasing inhibition and concentrations .56% decreasing inhibition ( Figure 6D ). This is explained by the stabilization of R-state character by mixed hybrid tetramers containing both ferric and ferrous Hb, leading to an increased nitrite reduction rate at low methaem concentrations, whereas at higher concentrations of methaem, the rate of nitrite reduction was decreased by a lack of nitrite-binding sites. As a control, this experiment was repeated using partially oxidized Hb mixtures obtained by mixing different ratios of fully oxidized (100% met) Hb with fully deoxygenated and reduced Hb tetramers. Addition of nitrite to mitochondria incubated with these mixtures showed a significantly different result compared with the mixed tetramers. As methaem percentage was increased, the extent of inhibition was decreased. This was due to the fact that in this case, increasing the concentration of methaem results solely in a decrease in nitrite-binding sites ( Figure 6D ).
Discussion
Here, we have described two assay systems in which we utilize inhibition of mitochondrial respiration as a sensor for NO generated by Hb-catalysed nitrite reduction. We have exploited this biological response to demonstrate that (i) the Hb-catalysed nitrite reduction generates bioavailable NO that is able to modulate distant targets Detection of nitrite-dependent NO generation by mitochondrial inhibition outside the RBC and (ii) the allosteric modulation of the Hb tetramer that increases the R-state character and increases the nitrite reductase reaction rate increases NO signalling.
The data presented here are the first to use a physiologically relevant, cGMP-independent method of confirming changes in NO production rates with allosteric modulation of Hb-catalysed nitrite reduction. This mitochondrial assay system provides several advantages over the detection of NO by intracellular cGMP. The major advantage of isolated mitochondria is their relative lack of endogenous nitrite reductase activity in comparison with cells which may contain several nitrite reductase enzymes (e.g. myoglobin in myocytes, xanthine oxidase in hepatocytes) that could confound the measurement of NO by Hb-mediated nitrite reduction. In addition, the ability of isolated mitochondria to rapidly and efficiently deoxygenate the experimental system lends to the ease of this assay and the ability to collect kinetic data compared with cell-based cGMP assays.
Although cytochrome c oxidase itself 36, 37 has been described as a nitrite reductase, this enzyme does not mediate nitrite reduction in the experiments presented here, based on the lack of effect of nitrite alone on mitochondrial respiration. However, it is important to note that at concentrations above 50 mM, a slight but significant inhibitory effect on respiration was observed in the presence of nitrite alone and in the absence of other nitrite reductases. This effect has previously been attributed to the direct binding of nitrite to cytochrome c oxidase, and it is possible that this binding leads to the production of NO. Indeed a similar method has been utilized to demonstrate that high micromolar concentrations of nitrite inhibit plant mitochondria during hypoxia.
38
A major strength of this technique is its ability to detect low concentrations of NO due to the sensitivity of mitochondrial respiration to NO. In the open-flow method described here, significant inhibition of respiration is required to sufficiently alter the rate of oxygen accumulation in the chamber enough to detect respiratory inhibition. We used the NO donor DetaNONOate to calculate that in the conditions used, 75-100 nM of NO is required to alter respiratory rate to a sufficient level to detect inhibition. Based on the accepted IC 50 of NO for cytochrome c oxidase (100 nM at 5-10 mM O 2 ) in isolated mitochondria, 27, 28 we estimate that at this level of hypoxia, 100 nM of NO results in an 60 -70% of respiratory inhibition. While this is a high percentage of respiratory inhibition, it is important to note that the ability to detect 100 nM NO renders this system relatively sensitive in comparison with other methods. Previous studies have demonstrated that the infusion of nitrite into the human forearm or the nebulization of nitrite in hypoxic sheep results in the dilation of the systemic and pulmonary vasculature, respectively. 18, 39 Moreover, these studies demonstrate that this vasodilatory response is mediated through the reaction of nitrite with Hb. Despite these studies, a principal challenge to the model of Hb-catalysed nitrite reduction as a mediator of hypoxic vasodilation is that the rapid reaction of NO with vicinal deoxyHb would preclude the escape of NO from the RBC. In the current studies, nitrite reduction catalysed by both RBCs and Hb was able to inhibit respiration, suggesting that at least 100 nM NO was able to escape haem scavenging within the time scale of the experiment. Given that the concentration of NO required to activate soluble guanylate cyclase is an order of magnitude lower (EC 50 ¼ 5-10 nM), these data support the idea that sufficient NO is able to leave the RBC to mediate vasodilation.
Although focus has been placed on the role of RBC-catalysed nitrite reduction in hypoxic vasodilation, this reaction has implications for the regulation of tissue metabolism as well. Hypoxic vasodilation is a fundamental response to a condition in which the metabolic needs of the tissue are greater than the delivery of oxygen to the tissues. 40, 41 Whereas increased delivery of oxygen is a compensatory mechanism in these conditions, another mechanism may be the downregulation of tissue oxygen consumption. This type of 'hibernation' response, in which metabolism is completely shut down during ischaemia, has been described in the heart. 42, 43 Similarly, in the vessel, during hypoxia, a small but significant decrease in oxygen consumption may prevent complete metabolic stress. Here, we have shown that nitrite-Hb-dependent inhibition of respiration can occur in both heart and liver mitochondria, suggesting that nitrite-Hb-dependent modulation of respiration may be a common mechanism in all organ systems. Consistent with the idea of downregulation of oxygen consumption without compromising energy production, it has been shown that NO can inhibit respiration by 35% without significantly altering energy production. 33 Physiologically, an oxygensensing mechanism that not only leads to the delivery of more oxygen, but also decreases the necessity for oxygen may be an optimal method for hypoxic adaptation.
Beyond vasodilation and modulation of metabolism, NO mediates a number of vascular responses including inhibition of platelet aggregation. The major source of NO in the vessel is generally regarded to be the endothelial nitric oxide synthase (eNOS). However, since oxygen is required for eNOS-dependent NO production, enzymatic NO generation becomes limited in hypoxic conditions. 44 In these conditions, Hb-catalysed nitrite reduction may represent an integral source of NO for the maintenance of vessel homeostasis. We have shown previously that the plasma protein ceruloplasmin oxidizes NO to nitrite in the blood. 45 Hence, a cycle may exist in which eNOS-generated NO is oxidized to nitrite in normoxia, and this nitrite reserve is reduced to NO by the RBC in hypoxia. This cycle may be particularly important in maintaining NO homeostasis for circulating cells such as platelets, which contain eNOS and also interact with RBCs. In summary, we have described a new method of detecting NO generation from the reduction of nitrite using the inhibition of cytochrome c oxidase as a physiological biosensor. Using this method, we have demonstrated here that NO bioavailability from RBC and Hb-catalysed nitrite reduction is regulated by oxygen and allosteric modulation of the Hb molecule. As new data emerge about existing nitrite reductases and novel nitrite reductase systems are discovered, this method can serve as a valuable tool for the physiological detection of NO.
